Isofol Medical AB (publ) (STO:ISOFOL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.8440
-0.0120 (-1.40%)
Aug 29, 2025, 5:29 PM CET
-1.40%
Market Cap237.25M
Revenue (ttm)n/a
Net Income (ttm)-52.29M
Shares Out281.11M
EPS (ttm)-0.33
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume378,017
Average Volume693,669
Open0.8565
Previous Close0.8560
Day's Range0.8405 - 0.8685
52-Week Range0.8425 - 4.3500
Beta1.16
RSI37.94
Earnings DateAug 26, 2025

About Isofol Medical AB

Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 5
Stock Exchange Nasdaq Stockholm
Ticker Symbol ISOFOL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.